Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Treatment strategies for polycythemia vera: Observations in a Dutch "real-world" cohort study.

van de Ree-Pellikaan C, de Kreuk A, Schaar CG, Beeker A, Dompeling EC, Gerrits CJH, van Houten AA, Schipperus MR, Strobbe L, Posthuma EFM, Klauke K, Westerweel PE.

Eur J Haematol. 2019 Nov;103(5):453-459. doi: 10.1111/ejh.13291. Epub 2019 Sep 5.

PMID:
31298768
2.

Economic burden of hypoglycemia with basal insulin in type 2 diabetes.

Fonseca V, Chou E, Chung HW, Gerrits C.

Am J Manag Care. 2017 Feb;23(2):114-122.

3.

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis.

Freemantle N, Chou E, Frois C, Zhuo D, Lehmacher W, Vlajnic A, Wang H, Chung HW, Zhang Q, Wu E, Gerrits C.

BMJ Open. 2016 Feb 15;6(2):e009421. doi: 10.1136/bmjopen-2015-009421. Review.

4.

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM.

Pharmacoeconomics. 2010;28(10):935-45. doi: 10.2165/11538370-000000000-00000.

PMID:
20831302
5.

Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).

Hauben M, Reich L, Gerrits CM, Madigan D.

Drug Saf. 2007;30(12):1143-9.

PMID:
18035866
6.

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.

Gerrits CM, Bhattacharya M, Manthena S, Baran R, Perez A, Kupfer S.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1065-71.

PMID:
17674425
7.

Down syndrome associated with hypothyroidism and chronic pericardial effusion: echocardiographic follow-up.

Said SA, Droste HT, Derks S, Gerrits CJ, Fast JH.

Neth Heart J. 2007;15(2):67-70.

8.

Illusions of objectivity and a recommendation for reporting data mining results.

Hauben M, Reich L, Gerrits CM, Younus M.

Eur J Clin Pharmacol. 2007 May;63(5):517-21. Epub 2007 Mar 16.

PMID:
17364192
9.

Data mining in pharmacovigilance: lessons from phantom ships.

Hauben M, Reich L, Van Puijenbroek EP, Gerrits CM, Patadia VK.

Eur J Clin Pharmacol. 2006 Nov;62(11):967-70. Epub 2006 Aug 3. No abstract available.

PMID:
16896782
10.

Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.

Hauben M, Reich L, Gerrits CM.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):775-83.

PMID:
16804951
11.

Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.

Hospers GA, Schaapveld M, Nortier JW, Wils J, van Bochove A, de Jong RS, Creemers GJ, Erjavec Z, de Gooyer DJ, Slee PH, Gerrits CJ, Smit JM, Mulder NH.

Ann Oncol. 2006 Mar;17(3):443-9.

12.

Perspectives on the use of data mining in pharmaco-vigilance.

Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C, Sacks ST, Yuen N, Patadia V, Blum M, Johnston M, Gerrits C, Seifert H, Lacroix K.

Drug Saf. 2005;28(11):981-1007. Review.

PMID:
16231953
13.

Data mining in pharmacovigilance: the need for a balanced perspective.

Hauben M, Patadia V, Gerrits C, Walsh L, Reich L.

Drug Saf. 2005;28(10):835-42.

PMID:
16180934
14.

The role of data mining in pharmacovigilance.

Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP.

Expert Opin Drug Saf. 2005 Sep;4(5):929-48. Review.

PMID:
16111454
15.

Persistence with inhaled corticosteroid therapy in daily practice.

Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM.

Respir Med. 2004 Aug;98(8):752-9.

16.

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.

Gerrits CM, Herings RM, Leufkens HG, Lammers JW.

Eur Respir J. 2003 May;21(5):795-8.

17.

Asthma exacerbations during first therapy with long acting beta 2-agonists.

Gerrits CM, Herings RM, Leufkens HG, Lammers JW.

Pharm World Sci. 1999 Jun;21(3):116-9.

PMID:
10427580
18.

A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)

Gerrits CJ, Schellens JH, Burris H, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Von Hoff DD, Verweij J.

Clin Cancer Res. 1999 Jan;5(1):69-75.

19.

Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours.

Gerrits CJ, Burris H, Schellens JH, Planting AS, van den Burg ME, Rodriguez GI, van Beurden V, Loos WJ, Hudson I, Fields S, Verweij J, von Hoff DD.

Eur J Cancer. 1998 Jun;34(7):1030-5.

PMID:
9849451
20.

Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.

Gerrits CJ, Burris H, Schellens JH, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Fields S, Von Hoff DD, Verweij J.

Clin Cancer Res. 1998 May;4(5):1153-8.

21.

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.

Creemers GJ, Gerrits CJ, Eckardt JR, Schellens JH, Burris HA, Planting AS, Rodriguez GI, Loos WJ, Hudson I, Broom C, Verweij J, Von Hoff DD.

J Clin Oncol. 1997 Mar;15(3):1087-93.

PMID:
9060549
22.

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Gerrits CJ, de Jonge MJ, Schellens JH, Stoter G, Verweij J.

Br J Cancer. 1997;76(7):952-62. Review.

23.

The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor.

Gerrits CJ, Schellens JH, Creemers GJ, Wissel P, Planting AS, Pritchard JF, DePee S, de Boer-Dennert M, Harteveld M, Verweij J.

Br J Cancer. 1997;76(7):946-51.

24.

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.

Creemers GJ, Gerrits CJ, Schellens JH, Planting AS, van der Burg ME, van Beurden VM, de Boer-Dennert M, Harteveld M, Loos W, Hudson I, Stoter G, Verweij J.

J Clin Oncol. 1996 Sep;14(9):2540-5.

PMID:
8823333
25.

Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.

van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, Lamberts SW, Löwenberg B.

Br J Haematol. 1996 Apr;93(1):96-103.

PMID:
8611482
26.

The relationship between sigmoidal intramucosal pH and intestinal arterial occlusion during aortic reconstructive surgery.

Klok T, Moll FL, Leusink JA, Theunissen DJ, Gerrits CM, Keijer C.

Eur J Vasc Endovasc Surg. 1996 Apr;11(3):304-7.

27.

Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration.

Gerrits CJ, Creemers GJ, Schellens JH, Wissel P, Planting AS, Kunka R, Selinger K, de Boer-Dennert M, Marijnen Y, Harteveld M, Verweij J.

Br J Cancer. 1996 Mar;73(6):744-50.

28.

[Chronic lymphocytic and prolymphocytic leukemia].

Gerrits CJ, Michiels JJ.

Ned Tijdschr Geneeskd. 1995 Apr 22;139(16):826-30. Review. Dutch. No abstract available.

PMID:
7731474
29.

Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.

Gerrits CJ, van Overhagen H, van Lom K, Adriaansen HJ, Löwenberg B.

Br J Haematol. 1994 Nov;88(3):626-8.

PMID:
7819079
30.
31.

[Evaluation of the roentgenological and endoscopic diagnosis in malignities of the proximal digestive tract].

Gerrits CJ, Enneking JH, de Koning RW.

Ned Tijdschr Geneeskd. 1990 Dec 15;134(50):2442-4. Dutch.

PMID:
2263275
32.

Magnetization steps in iron-based diluted magnetic semiconductors.

Swagten HJ, Gerrits CE, Twardowski A, de Jonge WJ.

Phys Rev B Condens Matter. 1990 Apr 1;41(10):7330-7333. No abstract available.

PMID:
9993021
33.

Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief.

Mulder CJ, Tijtgat GN, Cluysenaer OJ, Nicolai JJ, Meyer WW, Hazenberg BP, Vogten AJ, Gerrits C, Stuifbergen WH.

Aliment Pharmacol Ther. 1989 Oct;3(5):445-51.

PMID:
2518857
34.

A West African epilepsy focus.

Gerrits C.

Lancet. 1983 Feb 12;1(8320):358. No abstract available.

PMID:
6130361

Supplemental Content

Loading ...
Support Center